Skip to content
lifestyle.militaryparenting.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Lupin Pharmaceutical, Inc.
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
July 21, 2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 26, 2026
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 17, 2026
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
June 4, 2026